The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 awarded a single award blanket purchase agreement to Advanced Accelerator Applications USA Inc. to provide PLUVICTO and LUTATHERA radiopharmaceuticals. With a period of performance from December 1, 2022 through November 30, 2023 and a value of approximately $4.37 million, this firm fixed price contract utilizes Federal Supply Schedule 61-IB for Pharmaceuticals and Drugs. Performance will take place at VA medical facilities located in Millburn, New Jersey.
The originating solicitation sought to award a sole source blanket purchase agreement for a five year period to supply Theronastic radiopharmaceutical therapy agents Pluvicto and Lutathera to the St. Louis VAMC, located in St. Louis, Missouri. No set-aside was applied. Interested parties were invited to submit capability statements by September 16, 2022 to be considered, though the notice indicated the agency intended to negotiate solely with Advanced Accelerator Applications USA Inc., located in Millburn, New Jersey, if no other viable responses were received.
Generated 1/4/24, 4:38 PM